<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28754515</article-id>
<article-id pub-id-type="pmc">5723539</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2017.05.027</article-id>
<article-id pub-id-type="manuscript">NIHMS895602</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Maternal Systemic Interleukin-6 During Pregnancy is Associated with Newborn Amygdala Phenotypes and Subsequent Behavior at 2-years-of-age</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Graham</surname>
<given-names>Alice M.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>Jerod M.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rudolph</surname>
<given-names>Marc D.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heim</surname>
<given-names>Christine M.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gilmore</surname>
<given-names>John H.</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Styner</surname>
<given-names>Martin</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Potkin</surname>
<given-names>Steven G.</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Entringer</surname>
<given-names>Sonja</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wadhwa</surname>
<given-names>Pathik D.</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fair</surname>
<given-names>Damien A.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A7">g</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buss</surname>
<given-names>Claudia</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Department of Behavioral Neuroscience, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, 97239, United States</aff>
<aff id="A2">
<label>b</label>Development, Health and Disease Research Program, University of California, Irvine, 837 Health Sciences Drive, Irvine, California, 92697, United States</aff>
<aff id="A3">
<label>c</label>Department of Medical Psychology, Charité University of Medicine Berlin, Luisenstrasse 57, 10117 Berlin, Germany</aff>
<aff id="A4">
<label>d</label>Department of Biobehavioral Health, Pennsylvania State University</aff>
<aff id="A5">
<label>e</label>Department of Psychiatry, University of North Carolina, 333 South Columbia Street, Chapel Hill, North Carolina, 27514</aff>
<aff id="A6">
<label>f</label>Department of Psychiatry and Human Behavior, University of California, Irvine</aff>
<aff id="A7">
<label>g</label>Advanced Imaging Research Center, Oregon Health &amp; Science University</aff>
<author-notes>
<fn fn-type="COI-statement" id="FN3">
<p id="P36">
<bold>Financial Disclosures</bold>
</p>
<p id="P37">Dr. Graham reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P38">Dr. Rasmussen reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P39">Mr. Rudolph reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P40">Dr. Heim reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P41">Dr. Gilmore reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P42">Dr. Styner reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P43">Dr. Potkin reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P44">Dr. Entringer reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P45">Dr. Wadhwa reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P46">Dr. Fair reported no biomedical financial interests or potential conflicts of interest.</p>
<p id="P47">Dr. Buss reported no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>83</volume>
<issue>2</issue>
<fpage>109</fpage>
<lpage>119</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2017.05.027-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">Maternal inflammation during pregnancy increases risk for offspring psychiatric disorders and other adverse long-term health outcomes. The influence of inflammation on the developing fetal brain is hypothesized as one potential mechanism, but has not been examined in humans.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Participants were N=86 adult women recruited in early pregnancy, and their infants born after 34-weeks gestation. A biological indicator of maternal inflammation (interleukin-6 [IL-6]), which has been shown to influence fetal brain development in animal models, was quantified serially in early, mid and late pregnancy. Structural and functional brain MRI was acquired in neonates shortly after birth. Infants’ amygdalae were individually segmented for measures of volume and as seeds for resting state functional connectivity. At 24-months-of-age, children completed a snack delay task to assess impulse control.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Higher average maternal IL-6 concentration during pregnancy was prospectively associated with larger right amygdala volume and stronger bilateral amygdala connectivity to brain regions involved in sensory processing and integration (fusiform, somatosensory cortex, thalamus), salience detection (anterior insula), and learning and memory (caudate and parahippocampal gyrus). Larger newborn right amygdala volume and stronger left amygdala connectivity were in turn associated with lower impulse control at 24-months-of-age, and mediated the association between higher maternal IL-6 concentrations and lower impulse control.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">These findings provide new evidence in humans linking maternal inflammation during pregnancy with newborn brain and emerging behavioral phenotypes relevant for psychiatric disorders. A better understanding of intrauterine conditions that influence offspring disease susceptibility is warranted to inform targeted early intervention and prevention efforts.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Inflammation</kwd>
<kwd>pregnancy</kwd>
<kwd>neonates</kwd>
<kwd>neuroimaging</kwd>
<kwd>amygdala</kwd>
<kwd>resting state functional connectivity MRI</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>